Ahmet Emin Dogan

Dr. Ahmet Emin Dogan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AGALPER GÖK
ALPER GÖK
MAMehmet Altan
Mehmet Altan
ADAhmet Emin Dogan
Ahmet Emin Dogan
AEAşır Eraslan
Aşır Eraslan
FUFahrettin Şamil Uysal
Fahrettin Şamil Uysal
MIMuhammet Abdurrahim İmamoğlu
Muhammet Abdurrahim İmamoğlu
Background: Some studies have shown that there may be an increase in the frequency of erectile dysfunction after COVID-19. However, no long-term study has investigated whether this is permanent or temporary. In this study, we aimed to examine whether there was an increase in the frequency of erectile dysfunction among individuals with a history of COVID-19, and, if there was, whether their condition improved over time. Materials and methods: In this study, a total of 125 healthy male healthcare workers, 95 with and 30 without a history of COVID-19, were evaluated in terms of erectile function. Four study groups were formed. The first three groups consisted of individuals with a history of COVID-19 confirmed by the polymerase chain reaction (PCR) test at different times, who recovered from the disease (time elapsed since COVID-19 positivity: 12 months for Group 3). The individuals in Group 4 did not have a history of COVID-19 diagnosis. In order to evaluate the erectile function of the participants, they were asked to complete the five-item International Index of Erectile Function questionnaire (IIEF-5). Then, statistical analyses were performed to evaluate whether there was a difference between the groups in terms of the IIEF-5 scores. Results: There was a statistically significant difference between the groups in terms of the IIEF-5 scores (p < 0.001), and this difference was determined to be caused by the significantly higher IIEF-5 scores of Groups 3 and 4 compared to Group 1 (p = 0.004 and p < 0.001, respectively). In addition, the IIEF-5 score of Group 4 was statistically significantly higher than that of Group 2 (p < 0.001). However, the IIEF-5 scores did not statistically significantly differ between Groups 1 and 2, Groups 2 and 3, and Groups 3 and 4 (p > 0.999, p = 0.204, and p = 0.592, respectively). Conclusion: There may be deterioration in erectile function after COVID-19; however, this tends to improve over time, especially from the first year after active infection. Given that vascular, hormonal, and/or psychogenic factors may lead to the development of erectile dysfunction after COVID-19, we consider that in order to easily manage this process, it is important to determine the underlying cause, initiate appropriate treatment, and inform couples that this situation can be temporary.

1 September 2022 in Urology Research and Practice
Verified
Journal Article
Open access
AGAbdullah Gürel
Abdullah Gürel
BBBurhan Baylan
Burhan Baylan
IKIbrahim Keles
Ibrahim Keles
ADArif Demirbas
Arif Demirbas
MKMustafa Karalar
Mustafa Karalar
AMAhmet Yaser Müslümanoğlu
Ahmet Yaser Müslümanoğlu
Objective: The present study examines the effects of the coronavirus disease 2019 pandemic on radical prostatectomy performed as part of localized prostate cancer treatment in Turkey. Material and methods: A retrospective analysis was made of the data of 176 patients from 8 centers in Turkey who underwent radical prostatectomy due to localized prostate cancer over the 2 years spanning March 1, 2019, to February 28, 2021. Within this timeframe, March 1, 2019, to February 28, 2020, was denoted the 1-year pre-coronavirus disease 2019 period, while March 1, 2020, to February 28, 2021, was denoted the 1-year coronavirus disease 2019 period. An analysis was made of whether there was a difference in the number of radical prostatectomies performed for prostate cancer, the time from biopsy to operation, and the biopsy and radical prostatectomy pathology between the 2 periods. Results: It was found that the number of radical prostatectomies performed for localized prostate cancer during the coronavirus disease 2019 pandemic was statistically and highly significantly fewer than in the pre-coronavirus disease 2019 period (P <.001). The patients diagnosed with Gleason 3+3 (low risk) prostate cancer were statistically significantly fewer in number in the coronavirus disease 2019 period (P <.001). The pathological Gleason score was upgrading than the biopsy Gleason score in all patients who underwent in both periods (P <.001). When the periods were compared, the pathological involvement determined by lymph node dissection performed during radical prostatectomy was found to be decreased in the coronavirus disease 2019 period, although the difference was not statistically significant (P =.051). Conclusion: As with many diseases, the diagnosis and treatment of prostate cancer have been adversely affected by the coronavirus disease 2019 pandemic. Cite this article as: Gurel A, Baylan B, Keles I, et al. Effect of the COVID-19 pandemic on radical prostatectomy: A Turkish multicenter study. Turk J Urol. 2022;48(5):339-345.

11 March 2024 in Journal of Urological Surgery
Verified
Journal Article
Closed access
HSHilmi Sarı
Hilmi Sarı
BEBerk Yasin Ekenci
Berk Yasin Ekenci
HDHüsEyin Mert Durak
HüsEyin Mert Durak
GKGülSen Keskin
GülSen Keskin
ADAhmet Emin Dogan
Ahmet Emin Dogan
ASAzmi Levent Sağnak
Azmi Levent Sağnak

30 October 2024 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
ACAhmet Emre Cinislioğlu
Ahmet Emre Cinislioğlu
NCNazan Cinislioğlu
Nazan Cinislioğlu
MÖMetin İsHak Öztürk
Metin İsHak Öztürk
FAFatih Akkaş
Fatih Akkaş
TATugay Aksakallı
Tugay Aksakallı
AKAteş Kadıoğlu
Ateş Kadıoğlu
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.

16 January 2026 in Medicine
Verified
Journal Article
Open access
ADAhmet Emin Dogan
Ahmet Emin Dogan
AAAli Atan
Ali Atan
AUAli Unsal
Ali Unsal
FPFazli Polat
Fazli Polat
SYSuleyman Yesil
Suleyman Yesil
This retrospective study aimed to assess the impact of metabolic syndrome (MS) and its components on tumor size, Fuhrman grade (FG), and tumor-node-metastasis stage in patients with renal cell carcinoma (RCC). Data from 151 patients who underwent surgery for RCC between January 2010 and April 2018 were retrospectively reviewed. The criteria included blood test results, presence of chronic ailments, and body mass index. Tumor size, FG, and TNM stage were compared. The criteria for defining MS and statistical methods were used for the comparative investigation. Of the 151 patients operated for RCC in our clinic, the prevalence of MS, diabetes mellitus, hypertension (HT), dyslipidemia, and obesity was 27.2%, 29.1%, 41.1%, 64.9%, and 27.2%, respectively. Tumor size was significantly larger, and FG and TNM stages were more advanced in patients with MS than in patients without MS ( P = .046, P = .005, P = .030, respectively). The study revealed a statistically significant increase in tumor size associated with diabetes mellitus, HT, dyslipidemia (DysL), and obesity ( P = .017, P = .007, P < .001, P = .005, respectively). The TNM stage was significantly higher in patients with HT, DysL, and obesity ( P < .001, all of them). In patients undergoing surgery for RCC, MS, and its components showed a statistically significant correlation with tumor size. In addition, HT, DysL, and obesity were associated with a high TNM stage. These findings underscore the potential clinical relevance of addressing the metabolic factors in RCC management.

13 February 2026 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
ADAhmet Emin Dogan
Ahmet Emin Dogan
GÖGörkem Özenç
Görkem Özenç
IUIbrahim Untan
Ibrahim Untan
MAMehmet Altan
Mehmet Altan
MYMetin Yığman
Metin Yığman
HSHilmi Sarı
Hilmi Sarı
In the contemporary era, acquiring online information has become a prevalent practice. As with any affliction, individuals are inclined to investigate the potential therapeutic avenues for erectile dysfunction (ED) on the internet. To evaluate the quality, comprehensibility and informative content of YouTube videos on penile prosthesis implantation, with a focus on videos produced by healthcare professionals, and to address the videos according to the class of physician producing the video. A search for "penile prosthesis" was conducted on YouTube using a censored network to ensure privacy and prevent bias. The first 100 relevant videos uploaded in the last decade were analyzed. They were categorized by source (academicians, government or private hospital physicians, and non-physicians) and assessed for quality using the modified Quality Criteria for Consumer Health Information (DISCERN) scale, Global Quality Scale (GQS) and a newly developed Total Informative Score based on the European Association of Urology Patient Information Forms. The Kruskal-Wallis H test, Kendall's tau correlation test and Spearman's test were used for statistical analysis. Of the videos analyzed, 87% provided informative content, with the majority (51%) uploaded by academic sources. The median duration time was 185 s (111-397). The average modified DISCERN score was low (median: 2, Q1-Q3: 2-3), indicating generally inadequate quality, with 54% rated as poor. No statistical significance occurred between GQS scores for the videos published by the upload source. Videos by government hospital physicians scored the highest in quality measures, while non-physician videos garnered more views and likes. The Patient Education Materials Assessment Tool (PEMAT) understandability and actionability scores showed that videos from healthcare professionals had higher understandability (70%) than those from other sources. The overall quality of YouTube videos on penile prostheses is low, despite most being informative. Videos created by physicians are more reliable and easier to understand. Implementing stricter guidelines for content creators and promoting public awareness initiatives are recommended to improve patient access to high-quality information.